KILITCH DRUGS (INDIA)
Back to Balance Sheet
|
KILITCH DRUGS (INDIA) Last 5 Year Total Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Liabilities | ₹237 Cr | ₹218 Cr | ₹208 Cr | ₹202 Cr | ₹142 Cr |
What is the latest Total Liabilities ratio of KILITCH DRUGS (INDIA) ?
Year | Total Liabilities |
---|---|
Mar2024 | ₹237 Cr |
Mar2023 | ₹218 Cr |
Mar2022 | ₹208 Cr |
Mar2021 | ₹202 Cr |
Mar2020 | ₹142 Cr |
How is Total Liabilities of KILITCH DRUGS (INDIA) Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹237 Cr | 9.17 | |
Mar2023 | ₹218 Cr | 4.42 | |
Mar2022 | ₹208 Cr | 3.19 | |
Mar2021 | ₹202 Cr | 42.32 | |
Mar2020 | ₹142 Cr | - |
Compare Total Liabilities of peers of KILITCH DRUGS (INDIA)
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
KILITCH DRUGS (INDIA) | ₹523.4 Cr | 0.6% | 5.4% | -8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹433,920.0 Cr | -0.1% | 1.7% | 45.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹155,160.0 Cr | -0.1% | -2.2% | 56.9% | Stock Analytics | |
CIPLA | ₹118,917.0 Cr | 1.7% | 0.5% | 23.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹112,017.0 Cr | 5.7% | 12.4% | 18.5% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹97,997.1 Cr | -1.4% | 3.1% | 44.8% | Stock Analytics |
KILITCH DRUGS (INDIA) Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
KILITCH DRUGS (INDIA) | 0.6% |
5.4% |
-8% |
SENSEX | -5% |
0.6% |
9.2% |
You may also like the below Video Courses